AllianceBernstein’s CARGO Therapeutics CRGX Stock Holding History

AllianceBernstein’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,610	Closed	-$262K	–	3252
2025 Q2	$262K	Buy	63,610 +37,970	+148%	+$163K	﹤0.01%	2977
2025 Q1	$104K	Hold	25,640	–	–	﹤0.01%	3064
2024 Q4	$370K	Sell	25,640 -1,680	-6%	-$30.5K	﹤0.01%	2778
2024 Q3	$504K	Buy	27,320 +1,460	+6%	+$26.1K	﹤0.01%	2661
2024 Q2	$425K	Buy	25,860 +4,560	+21%	+$86.7K	﹤0.01%	2756
2024 Q1	$475K	Buy	+21,300	New	+$507K	﹤0.01%	2602

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AllianceBernstein's CRGX Position: Q3 2025 in Review

AllianceBernstein sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 63,610 shares — an estimated $262K sold.

AllianceBernstein first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $504K in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

AllianceBernstein reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
AllianceBernstein sold 63,610 CARGO Therapeutics shares in Q3 2025, an estimated $262K.
AllianceBernstein first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
AllianceBernstein's CARGO Therapeutics position peaked at $504K in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on AllianceBernstein's 13F filing for Q3 2025, filed 14 Nov 2025.